Dr. Jason Rich, M.D.
Claim this profileWashington University School of Medicine
Studies Squamous Cell Carcinoma
Studies Thyroid Cancer
6 reported clinical trials
11 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage III
p16 positive
p16 negative
2Thyroid Cancer
Stage III
p16 positive
p16 negative
Affiliated Hospitals
Clinical Trials Jason Rich, M.D. is currently running
Chemotherapy and Radiation
for Cutaneous Angiosarcoma
Angiosarcoma is a rare and aggressive form of soft tissue sarcoma. Prior work demonstrates very poor outcomes, with most patients developing metastatic disease and less than 50% surviving greater than 5 years. In other soft tissue sarcomas, the use of radiotherapy and/or chemotherapy have improved progression-free survival in patients undergoing limited, organ-sparing surgeries. Taxane chemotherapy has shown efficacy in patients with metastatic angiosarcoma, but this has not been tested in patients with localized disease. This study examines the efficacy of induction paclitaxel followed by concurrent chemoradiation therapy with paclitaxel prior to curative surgical resection.
Recruiting1 award Phase 1 & 27 criteria
Online Peri-operative Education
for Head and Neck Cancer Surgery
This phase of the project will evaluate the utility and efficacy of a personalized online patient education platform developed from efforts in Phase 1 in 1) increasing patients' and caregivers' pre- and post-operative preparedness and satisfaction, and 2) reducing readmission, ED/Urgent care/unplanned clinic visits and telephone calls to clinic staff.
Recruiting1 award N/A
More about Jason Rich, M.D.
Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jason Rich, M.D. has experience with
- Cisplatin
- Radiation Therapy
- CareOrbit
- Cetuximab
- Intensity-Modulated Radiation Therapy
- Palbociclib
Breakdown of trials Jason Rich, M.D. has run
Squamous Cell Carcinoma
Thyroid Cancer
Head and Neck Cancers
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jason Rich, M.D. specialize in?
Jason Rich, M.D. focuses on Squamous Cell Carcinoma and Thyroid Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage III patients, or patients who are p16 positive.
Is Jason Rich, M.D. currently recruiting for clinical trials?
Yes, Jason Rich, M.D. is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Jason Rich, M.D. has studied deeply?
Yes, Jason Rich, M.D. has studied treatments such as Cisplatin, Radiation therapy, CareOrbit.
What is the best way to schedule an appointment with Jason Rich, M.D.?
Apply for one of the trials that Jason Rich, M.D. is conducting.
What is the office address of Jason Rich, M.D.?
The office of Jason Rich, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.